is semaglutide being discontinued The Shortage Ending: What's Next For Compounded Drugs? FDA ends semaglutide shortage, closing

doi: 10.2147/JIR.S430730, 56

As investors cheered the pivot to a more convenient, non-injectable alternative for obesity treatment, LLY broke above its 20-day moving average (MA), indicating the upward momentum may sustain in the near-term

These side effects are normal and typically resolve on their own within a day or two of treatment

A recent 2025 study showed that participants who consumed 1 gram of berberine daily for 6 months had no meaningful change in adiposity (AKA the accumulation of body fat) 19

ACT 3: The Strategic Verdict Stop Chasing, Start Planning The availability of increasingly effective treatments on the horizon often produces a specific kind of decision paralysis in health-savvy patients: the perpetual wait

Su X, Wang S, Zhang H, Yang G, Bai Y, Liu P, et al